英国二级保健中 COVID-19 相关糖尿病酮症酸中毒的高患病率。
High prevalence of COVID-19-associated diabetic ketoacidosis in UK secondary care.
机构信息
Department of Respiratory Medicine, Whipps Cross University Hospital, London, UK.
Department of Infectious Diseases, Whipps Cross University Hospital, London, UK.
出版信息
Diabetes Res Clin Pract. 2020 Aug;166:108291. doi: 10.1016/j.diabres.2020.108291. Epub 2020 Jun 29.
Abstract
We aim to describe the prevalence of diabetic ketoacidosis (DKA) in individuals admitted to a single centre with COVID-19. We identified 218 individuals hospitalised with COVID-19, of these four fulfilled criteria for DKA (4/218, 1.8%). We conclude DKA is common and severe in individuals hospitalised with COVID-19.
摘要
我们旨在描述在单一中心因 COVID-19 住院的个体中糖尿病酮症酸中毒（DKA）的患病率。我们共确定了 218 名因 COVID-19 住院的个体，其中有 4 人符合 DKA 的标准（4/218，1.8%）。我们的结论是，COVID-19 住院患者中 DKA 较为常见且严重。
相似文献
1
High prevalence of COVID-19-associated diabetic ketoacidosis in UK secondary care.英国二级保健中 COVID-19 相关糖尿病酮症酸中毒的高患病率。
Diabetes Res Clin Pract. 2020 Aug;166:108291. doi: 10.1016/j.diabres.2020.108291. Epub 2020 Jun 29.
2
Clinical characteristics and outcome in patients with combined diabetic ketoacidosis and hyperosmolar hyperglycemic state associated with COVID-19: A retrospective, hospital-based observational case series.与 COVID-19 相关的合并糖尿病酮症酸中毒和高渗高血糖状态患者的临床特征和结局：一项回顾性、基于医院的观察性病例系列研究。
Diabetes Res Clin Pract. 2020 Aug;166:108279. doi: 10.1016/j.diabres.2020.108279. Epub 2020 Jun 25.
3
Diabetic ketoacidosis during COVID-19 pandemic in a developing country.发展中国家在新冠疫情期间的糖尿病酮症酸中毒
Diabetes Res Clin Pract. 2020 Oct;168:108391. doi: 10.1016/j.diabres.2020.108391. Epub 2020 Aug 25.
4
Clinical characteristics and outcomes of COVID-19 hospitalized patients with diabetes in the United Kingdom: A retrospective single centre study.英国 COVID-19 住院糖尿病患者的临床特征和结局：一项回顾性单中心研究。
Diabetes Res Clin Pract. 2020 Jul;165:108263. doi: 10.1016/j.diabres.2020.108263. Epub 2020 Jun 10.
5
Diabetic Ketoacidosis in COVID-19: Unique Concerns and Considerations.新型冠状病毒肺炎合并糖尿病酮症酸中毒：特殊关注点与注意事项
J Clin Endocrinol Metab. 2020 Aug 1;105(8). doi: 10.1210/clinem/dgaa360.
6
Diabetic ketoacidosis precipitated by COVID-19: A report of two cases and review of literature.由新型冠状病毒肺炎引发的糖尿病酮症酸中毒：两例报告及文献综述
Diabetes Metab Syndr. 2020 Sep-Oct;14(5):1459-1462. doi: 10.1016/j.dsx.2020.07.050. Epub 2020 Aug 1.
7
Severe diabetic ketoacidosis and coronavirus disease 2019 (COVID-19) infection in a teenage patient with newly diagnosed diabetes.一名新诊断糖尿病的青少年患者出现严重糖尿病酮症酸中毒和2019冠状病毒病（COVID-19）感染。
J Pediatr Endocrinol Metab. 2020 Sep 25;33(9):1241-1243. doi: 10.1515/jpem-2020-0296.
8
COVID-19 in patients with sickle cell disease - a case series from a UK Tertiary Hospital.镰状细胞病患者的新型冠状病毒肺炎——来自英国一家三级医院的病例系列
Haematologica. 2020 Nov 1;105(11):2691-2693. doi: 10.3324/haematol.2020.254250.
9
Has COVID-19 Delayed the Diagnosis and Worsened the Presentation of Type 1 Diabetes in Children?新冠疫情是否延迟了儿童 1 型糖尿病的诊断并加重了其临床表现？
Diabetes Care. 2020 Nov;43(11):2870-2872. doi: 10.2337/dc20-1321. Epub 2020 Aug 10.
10
COVID-19 and sickle cell disease.新型冠状病毒肺炎与镰状细胞病
Haematologica. 2020 Nov 1;105(11):2501-2504. doi: 10.3324/haematol.2020.255398.
引用本文的文献
1
The impact of diabetes and obesity on the severity and mortality of SARS-CoV-2 infection.糖尿病和肥胖对严重急性呼吸综合征冠状病毒2（SARS-CoV-2）感染的严重程度和死亡率的影响。
J Diabetes Metab Disord. 2025 Sep 1;24(2):195. doi: 10.1007/s40200-025-01706-5. eCollection 2025 Dec.
2
Effectiveness of Dexamethasone for COVID-19 in Hospitalized Patients With Diabetes: A Retrospective Cohort Study.地塞米松对住院糖尿病患者新型冠状病毒肺炎的疗效：一项回顾性队列研究。
J Clin Endocrinol Metab. 2025 Jun 17;110(7):1846-1853. doi: 10.1210/clinem/dgae734.
3
Inflammatory biomarkers predict higher risk of hyperglycemic crises but not outcomes in diabetic patients with COVID-19.炎症生物标志物可预测 COVID-19 合并糖尿病患者发生高血糖危象的风险更高，但不能预测结局。
Front Endocrinol (Lausanne). 2024 Feb 15;15:1287795. doi: 10.3389/fendo.2024.1287795. eCollection 2024.
4
Secondary fungal infections in SARS-CoV-2 patients: pathological whereabouts, cautionary measures, and steadfast treatments.SARS-CoV-2 患者继发真菌感染：病理途径、警示措施和坚定治疗。
Pharmacol Rep. 2023 Aug;75(4):817-837. doi: 10.1007/s43440-023-00506-z. Epub 2023 Jun 24.
5
Clinical profile and outcome of critically ill COVID-19 patients with diabetic ketoacidosis: A single-centre cross-sectional study in South India.患有糖尿病酮症酸中毒的重症 COVID-19 患者的临床特征与结局：印度南部的一项单中心横断面研究。
Indian J Anaesth. 2023 Mar;67(3):309-313. doi: 10.4103/ija.ija_368_22. Epub 2023 Mar 16.
6
Multiple influences of the COVID-19 pandemic on children with diabetes: Changes in epidemiology, metabolic control and medical care.新冠疫情对糖尿病患儿的多重影响：流行病学、代谢控制及医疗护理方面的变化
World J Diabetes. 2023 Mar 15;14(3):198-208. doi: 10.4239/wjd.v14.i3.198.
7
Alterations of adipokines, pancreatic hormones and incretins in acute and convalescent COVID-19 children.急性和恢复期 COVID-19 患儿中脂肪因子、胰激素和肠促胰岛素的变化。
BMC Pediatr. 2023 Apr 3;23(1):156. doi: 10.1186/s12887-023-03971-w.
8
Stress hyperglycemia, Diabetes mellitus and COVID-19 infection: The impact on newly diagnosed type 1 diabetes.应激性高血糖、糖尿病与新型冠状病毒肺炎感染：对新诊断1型糖尿病的影响
Front Clin Diabetes Healthc. 2022 Aug 29;3:818945. doi: 10.3389/fcdhc.2022.818945. eCollection 2022.
9
Bidirectional Relationship between Glycemic Control and COVID-19 and Perspectives of Islet Organoid Models of SARS-CoV-2 Infection.血糖控制与2019冠状病毒病之间的双向关系以及严重急性呼吸综合征冠状病毒2感染的胰岛类器官模型的前景
Biomedicines. 2023 Mar 11;11(3):856. doi: 10.3390/biomedicines11030856.
10
COVID-19 and diabetes in 2020: a systematic review.2020年新型冠状病毒肺炎与糖尿病：一项系统综述
J Pharm Policy Pract. 2023 Mar 9;16(1):42. doi: 10.1186/s40545-023-00546-z.
本文引用的文献
1
Type 1 diabetes triggered by covid-19 pandemic: A potential outbreak?由新冠疫情引发的1型糖尿病：会有潜在爆发吗？
Diabetes Res Clin Pract. 2020 Jun;164:108219. doi: 10.1016/j.diabres.2020.108219. Epub 2020 May 20.
2
Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes.COVID-19 合并 2 型糖尿病患者的血糖控制与结局的相关性。
Cell Metab. 2020 Jun 2;31(6):1068-1077.e3. doi: 10.1016/j.cmet.2020.04.021. Epub 2020 May 1.
3
Inhibitors of the Renin-Angiotensin-Aldosterone System and Covid-19.肾素-血管紧张素-醛固酮系统抑制剂与新型冠状病毒肺炎
N Engl J Med. 2020 Jun 18;382(25):2462-2464. doi: 10.1056/NEJMe2012924. Epub 2020 May 1.
4
The trinity of COVID-19: immunity, inflammation and intervention.COVID-19 的三位一体：免疫、炎症和干预。
Nat Rev Immunol. 2020 Jun;20(6):363-374. doi: 10.1038/s41577-020-0311-8. Epub 2020 Apr 28.
5
Practical recommendations for the management of diabetes in patients with COVID-19.关于 COVID-19 患者糖尿病管理的实用建议。
Lancet Diabetes Endocrinol. 2020 Jun;8(6):546-550. doi: 10.1016/S2213-8587(20)30152-2. Epub 2020 Apr 23.
6
Endocrine and metabolic link to coronavirus infection.内分泌和代谢与冠状病毒感染的关联。
Nat Rev Endocrinol. 2020 Jun;16(6):297-298. doi: 10.1038/s41574-020-0353-9.
7
COVID-19 and diabetes: Can DPP4 inhibition play a role?2019冠状病毒病与糖尿病：二肽基肽酶4抑制作用能否发挥作用？
Diabetes Res Clin Pract. 2020 Apr;162:108125. doi: 10.1016/j.diabres.2020.108125. Epub 2020 Mar 26.
8
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.中国武汉成人 COVID-19 住院患者的临床病程和死亡危险因素：一项回顾性队列研究。
Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11.
9
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.严重急性呼吸综合征冠状病毒 2 型（SARS-CoV-2）进入细胞依赖于 ACE2 和 TMPRSS2，可被一种临床验证的蛋白酶抑制剂所阻断。
Cell. 2020 Apr 16;181(2):271-280.e8. doi: 10.1016/j.cell.2020.02.052. Epub 2020 Mar 5.
10
Trends in Hospital Admission for Diabetic Ketoacidosis in Adults With Type 1 and Type 2 Diabetes in England, 1998-2013: A Retrospective Cohort Study.1998 年至 2013 年期间英国 1 型和 2 型糖尿病患者因糖尿病酮症酸中毒住院的趋势：一项回顾性队列研究。
Diabetes Care. 2018 Sep;41(9):1870-1877. doi: 10.2337/dc17-1583. Epub 2018 Jan 31.
Zotero 插件